Rationale for the Use of Histone Deacetylase Inhibitors as a Dual Therapeutic Modality in Multiple Sclerosis
- 1 April 2006
- journal article
- review article
- Published by Taylor & Francis in Epigenetics
- Vol. 1 (2) , 67-75
- https://doi.org/10.4161/epi.1.2.2678
Abstract
Major recent advances in the field of chromatin remodeling have dramatically changed our understanding of the ways in which genes are regulated. Epigenetic regulators such as histone deacetylases (...Keywords
This publication has 0 references indexed in Scilit: